- Filed
- Jan 23, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2025 · Dec 31, 2025 | 4.34B sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 4.39B sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2023 | 4.49B sh |
| Shares Outstanding | FY 2025 · Dec 31, 2025 | 4.22B sh |
| Stock Repurchased | FY 2025 · Dec 31, 2025 | $9.13B |
| Stock Repurchased | FY 2025 · Dec 31, 2024 | $6.26B |
| Stock Repurchased | FY 2025 · Dec 31, 2023 | $6.05B |
| Capex | FY 2025 · Dec 31, 2025 | $688.22M |
| Capex | FY 2025 · Dec 31, 2024 | $439.54M |
| Capex | FY 2025 · Dec 31, 2023 | $348.55M |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | $10.15B |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | $7.36B |
| Operating Cash Flow | FY 2025 · Dec 31, 2023 | $7.27B |
| Long Term Debt | FY 2025 · Dec 31, 2025 | $13.46B |
| Long Term Debt | FY 2025 · Dec 31, 2024 | $13.8B |
| Short Term Debt | FY 2025 · Dec 31, 2025 | $998.87M |
| Short Term Debt | FY 2025 · Dec 31, 2024 | $1.78B |
| Short Term Investments | FY 2025 · Dec 31, 2025 | $28.68M |
| Short Term Investments | FY 2025 · Dec 31, 2024 | $1.78B |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $9.03B |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $7.8B |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $26.62B |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $24.74B |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $20.59B |
| Stockholders Equity | FY 2025 · Dec 31, 2022 | $20.78B |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $10.98B |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $10.76B |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $28.98B |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $28.89B |
| Current Assets | FY 2025 · Dec 31, 2025 | $13.02B |
| Current Assets | FY 2025 · Dec 31, 2024 | $13.1B |
| Total Assets | FY 2025 · Dec 31, 2025 | $55.6B |
| Total Assets | FY 2025 · Dec 31, 2024 | $53.63B |
| Eps Diluted | FY 2025 · Dec 31, 2025 | $2.53 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | $1.98 |
| Eps Diluted restated | FY 2025 · Dec 31, 2023 | $1.20 |
| Eps Basic | FY 2025 · Dec 31, 2025 | $2.58 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | $2.03 |
| Eps Basic restated | FY 2025 · Dec 31, 2023 | $1.22 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $1.89B |
| Sga Expense | FY 2025 · Dec 31, 2024 | $1.7B |
| Sga Expense | FY 2025 · Dec 31, 2023 | $1.72B |
| Rd Expense | FY 2025 · Dec 31, 2025 | $3.39B |
| Rd Expense | FY 2025 · Dec 31, 2024 | $2.93B |
| Rd Expense | FY 2025 · Dec 31, 2023 | $2.68B |
| Net Income | FY 2025 · Dec 31, 2025 | $10.98B |
| Net Income | FY 2025 · Dec 31, 2024 | $8.71B |
| Net Income | FY 2025 · Dec 31, 2023 | $5.41B |
| Operating Income | FY 2025 · Dec 31, 2025 | $13.33B |
| Operating Income | FY 2025 · Dec 31, 2024 | $10.42B |
| Operating Income | FY 2025 · Dec 31, 2023 | $6.95B |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $23.28B |
| Cost Of Revenue | FY 2025 · Dec 31, 2024 | $21.04B |
| Cost Of Revenue | FY 2025 · Dec 31, 2023 | $19.72B |
| Revenue | FY 2025 · Dec 31, 2025 | $45.18B |
| Revenue | FY 2025 · Dec 31, 2024 | $39B |
| Revenue | FY 2025 · Dec 31, 2023 | $33.72B |